Which patents cover Theroxidil, and when can generic versions of Theroxidil launch?
Theroxidil is a drug marketed by Pure Source and is included in two NDAs.
The generic ingredient in THEROXIDIL is minoxidil. There are eight drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theroxidil
A generic version of THEROXIDIL was approved as minoxidil by WATSON LABS on March 3rd, 1987.
Market Dynamics and Financial Trajectory of Minoxidil
Market Overview
The global minoxidil market is a dynamic and growing sector, driven by several key factors including increasing research and development, expanding product portfolios, and rising consumer demand for hair care products.
Market Size and Growth
The global minoxidil market was valued at US$ 1,095.5 million in 2023 and is expected to exhibit a Compound Annual Growth Rate (CAGR) of 4.8% from 2023 to 2030, reaching a projected value of US$ 1,521.1 million by 2030[1].
Alternatively, the market is estimated to reach $1,637.7 million by 2030, growing at a CAGR of 5.2% from 2023 to 2030, or even exceed $1.89 billion by 2033 with a CAGR of 4.65% from 2023 to 2033[1][4].
Regional Revenue Streams
North America is expected to hold the largest share of the global minoxidil market, driven by growing end-user demand and sufficient supply from key manufacturers. This region is projected to be worth over USD 1.3 billion by 2032[4].
Europe is also anticipated to show rapid growth due to the substantial number of clinical studies and favorable market conditions[3].
Key Drivers
Increasing Research and Development
The market is driven by increasing research and development activities aimed at expanding the use of minoxidil beyond hair loss treatment. For instance, oral minoxidil is being explored for the treatment of late alopecia in cancer patients[1].
Inorganic Growth Strategies
Key market players are engaging in collaborations and agreements to expand their product portfolios. For example, Hims & Hers Health, Inc. collaborated with Walmart to distribute its hair care solutions, including minoxidil products[1].
Consumer Expenditure on Hair Care
A significant rise in consumer expenditure on hair care products, coupled with the expansion of product distribution channels, is fostering market growth. The easy access to products and a broad distribution network, including online pharmacies, are key factors[4].
Market Segmentation
The global minoxidil market is segmented based on type, route of administration, gender, distribution channel, and region. The 5% concentration segment is expected to grow at over 5% CAGR from 2023 to 2032, driven by its increasing usage in hair care formulations[4].
Distribution Channels
Key distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies. The expanding e-commerce sector, particularly due to the increasing trend of e-prescriptions and e-prescribing technology, has significantly contributed to minoxidil sales through online pharmacies[4].
Competitive Analysis
Key Players
Johnson & Johnson (J&J): A prominent player with a well-established reputation and extensive resources in production and distribution[1].
Taisho Pharma: Known for its strategies and innovations in the development and growth of the minoxidil market[1].
Hims & Hers Health, Inc.: A telehealth platform that has successfully entered the market with its high-quality hair care solutions, including minoxidil products[1][3].
Other Notable Companies
Other key players such as Par Pharmaceuticals, Provizer Pharma, and Bakul Group of companies also play a crucial role in shaping the market dynamics through their core competencies and competitive strategies[1].
Challenges and Limitations
Gradual Results and Maintenance
Minoxidil hair loss treatment requires consistent use over several months to see noticeable results, and discontinuing use can lead to a reversal of any hair growth achieved[2].
Limited Effectiveness
The effectiveness of minoxidil can vary among individuals, and it may not be suitable for all types of hair loss, which can limit its market growth[2].
COVID-19 Impact
The COVID-19 pandemic had a negative impact on the global minoxidil market due to disruptions in production, demand, and distribution channels. However, the market has been recovering as restrictions ease and normal operations resume[1].
Cross-Sectional Analysis
Increasing inorganic growth strategies in regions like the Asia Pacific are expected to drive market growth. For instance, Jupiter Wellness, Inc. signed agreements for the manufacture, sale, and distribution of cosmetic products in several countries in the Asia Pacific and the Middle East[1].
Key Trends
The growing prevalence of hair disorders such as dry hair, hair fall, and hair loss due to increasing pollution levels and other factors has led to a higher demand for hair care products, including minoxidil[4].
Restraints
Despite the market's growth potential, it faces restraints such as the gradual results of minoxidil treatment and the limited effectiveness for certain types of hair loss[2].
Illustrative Statistics
The U.S. minoxidil industry size exceeded USD 600 million in 2020 and is estimated to grow at over 4.35% CAGR through 2027[4].
The weekly rate of first-time minoxidil prescriptions per 10,000 outpatient encounters increased significantly after media attention about oral minoxidil, highlighting the impact of public awareness on market dynamics[5].
Expert Insights
"We’re the front door of the doctor’s office," said Andrew Dudum, Hims’ founder and CEO. "We are completely different from anything in the healthcare system."[3]
Key Takeaways
The global minoxidil market is projected to grow significantly, driven by research and development, inorganic growth strategies, and increasing consumer demand.
North America is expected to dominate the market, with Europe and the Asia Pacific also showing promising growth.
Key players like J&J and Taisho Pharma play a crucial role in market dynamics.
Despite challenges, the market holds substantial growth opportunities.
Frequently Asked Questions (FAQs)
What is the projected market size of the global minoxidil market by 2030?
The global minoxidil market is estimated to reach $1,521.1 million by 2030[1].
What is the CAGR of the global minoxidil market from 2023 to 2033?
The market is expected to grow at a CAGR of 4.65% from 2023 to 2033[4].
Which region is expected to hold the largest share in the global minoxidil market?
North America is expected to hold the largest share in the global minoxidil market[1][4].
What are the key distribution channels for minoxidil?
Key distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies[1][4].
What are the main challenges faced by the minoxidil market?
The main challenges include gradual results and maintenance, limited effectiveness, and the impact of the COVID-19 pandemic on production and distribution[1][2].
Cited Sources:
Coherent Market Insights: Minoxidil Market Size, Trends and Forecast to 2030[1].
Drug Patent Watch: Generic MINOXIDIL INN equivalents, pharmaceutical patent expiry[2].
Los Angeles Times: Young start-up Hims sells generic Viagra and Rogaine to the modern man[3].
Global Market Insights: Minoxidil Market Share, 2023-2032 | Industry Forecast Report[4].
JAMA Network Open: Changes in Minoxidil Prescribing After Media Attention About Oral Minoxidil[5].
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
